| 000 | 00993 a2200277 4500 | ||
|---|---|---|---|
| 005 | 20250514211739.0 | ||
| 264 | 0 | _c20041217 | |
| 008 | 200412s 0 0 eng d | ||
| 022 | _a1460-2105 | ||
| 024 | 7 |
_a10.1093/jnci/96.23.1740 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRandal, Judith | |
| 245 | 0 | 0 |
_aLicense to test cancer vaccines in U.S. a victory for Cuban biotechnology. _h[electronic resource] |
| 260 |
_bJournal of the National Cancer Institute _cDec 2004 |
||
| 300 |
_a1740-2 p. _bdigital |
||
| 500 | _aPublication Type: News | ||
| 650 | 0 | 4 |
_aCancer Vaccines _xadministration & dosage |
| 650 | 0 | 4 | _aCuba |
| 650 | 0 | 4 |
_aErbB Receptors _ximmunology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLicensure |
| 650 | 0 | 4 |
_aTransforming Growth Factor alpha _ximmunology |
| 650 | 0 | 4 | _aUnited States |
| 773 | 0 |
_tJournal of the National Cancer Institute _gvol. 96 _gno. 23 _gp. 1740-2 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/jnci/96.23.1740 _zAvailable from publisher's website |
| 999 |
_c15258084 _d15258084 |
||